QALY = quality-adjusted life year; ICER = incremental cost-effectiveness ratio; base = cheapest alternative; dom = dominated. Results are shown as means and 95% credibility intervals.
Dataset of the DROP project, with relevant variables for the cost-effectiveness study. For details about this research project, see the study protocol in: Aragonès, E., López-Cortacans, G., Caballero,
IntroductionPatients with a penicillin allergy label (PAL) use more and broader-spectrum antibiotics, have worse health outcomes and cost more to treat than patients without a PAL. A significant propo
